A thousand new regulators
FDA will add 1,163 new employees to its staff by the end of the fiscal year, according to the agency. One thousand and five already are on board and 158 are due to report by Sept. 28. Another 160 candidates have accepted offers but are still undergoing clearance and related security processes, FDA says. The new hires, the result of a staffing initiative launched in the spring, will increase agency personnel to authorized levels (1"The Pink Sheet," May 5, 2008, p. 7). More than 850 of the new staff are in scientific or medical professions
You may also be interested in...
As Congress debates increased funding and other steps to improve FDA oversight of imported drugs, the agency plans to hire 1,317 people in the next six months to bring staff numbers up to their full authorized levels
Cipla believes it is “pretty close” to approval for its Advair generic in the US, while another product, generic Abraxane, stands delayed currently. Following the deal with Ethris, which is progressing inhaled mRNA-based therapies, the company signals interest in platforms such as CAR-T as well.
In an interview, OND Deputy Director of Operations Kevin Bugin describes how FDA might be able to "accelerate" the transition back to in-person meetings if the initial phase with Type A and BPD Type 1 meetings goes well. But there is still no plan to return to in-person advisory committees.